[{"id":"8f748a9b-c17f-42d9-8728-effdcd01b43a","acronym":"","url":"https://clinicaltrials.gov/study/NCT01287520","created_at":"2021-01-18T05:13:35.060Z","updated_at":"2024-07-02T16:37:02.499Z","phase":"Phase 1","brief_title":"A Study of LY2090314 in Patients With Advanced or Metastatic Cancer","source_id_and_acronym":"NCT01287520","lead_sponsor":"Eli Lilly and Company","biomarkers":" CTNNB1","pipe":"","alterations":" ","tags":["CTNNB1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e carboplatin • pemetrexed • LY2090314"],"overall_status":"Completed","enrollment":" Enrollment 41","initiation":"Initiation: 11/01/2007","start_date":" 11/01/2007","primary_txt":" Primary completion: 04/01/2011","primary_completion_date":" 04/01/2011","study_txt":" Completion: 04/01/2011","study_completion_date":" 04/01/2011","last_update_posted":"2019-02-25"}]